Your browser doesn't support javascript.
loading
Managing Modern Antiretroviral Therapy in the Intensive Care Unit: Overcoming Challenges for Critically Ill People With Human Immunodeficiency Virus.
Chastain, Daniel B; Tu, Patrick J; Brizzi, Marisa; Keedy, Chelsea A; Baker, Aubrey N; Jackson, Brittany T; Ladak, Amber F; Hamilton, Leslie A; Sells, Nicholas R; Henao-Martínez, Andrés F; McManus, Kathleen A; Cluck, David B.
Afiliación
  • Chastain DB; Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, Georgia, USA.
  • Tu PJ; Department of Pharmacy, Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, USA.
  • Brizzi M; Department of Pharmacy, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
  • Keedy CA; Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Savannah, Georgia, USA.
  • Baker AN; Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, Georgia, USA.
  • Jackson BT; Department of Pharmacy, Mount Sinai Morningside, New York, New York, USA.
  • Ladak AF; Division of Infectious Diseases, Augusta University, Augusta, Georgia, USA.
  • Hamilton LA; College of Pharmacy, University of Tennessee Health Science Center, Knoxville, Tennessee, USA.
  • Sells NR; Division of Infectious Diseases, Mount Sinai Morningside, New York, New York, USA.
  • Henao-Martínez AF; Division of Infectious Diseases, University of Colorado, Aurora, Colorado, USA.
  • McManus KA; Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Cluck DB; Department of Pharmacy, University of Virginia Health, Charlottesville, Virginia, USA.
Open Forum Infect Dis ; 11(5): ofae213, 2024 May.
Article en En | MEDLINE | ID: mdl-38715574
ABSTRACT
People with human immunodeficiency virus (HIV) have a 50% excess risk for intensive care unit (ICU) admission, often for non-HIV-related conditions. Despite this, clear guidance for managing antiretroviral therapy (ART) in this setting is lacking. Selecting appropriate ART in the ICU is complex due to drug interactions, absorption issues, and dosing adjustments. Continuing ART in the ICU can be challenging due to organ dysfunction, drug interactions, and formulary limitations. However, with careful consideration, continuation is often feasible through dose adjustments or alternative administration methods. Temporary discontinuation of ART may be beneficial depending on the clinical scenario. Clinicians should actively seek resources and support to mitigate adverse events and drug interactions in critically ill people with HIV. Navigating challenges in the ICU can optimize ART and improve care and outcomes for critically ill people with HIV. This review aims to identify strategies for addressing the challenges associated with the use of modern ART in the ICU.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos